We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




批准快速链球菌聚合酶链反应用于传统临床实验室以外的检查

By LabMedica International staff writers
Posted on 27 Jul 2015
Cobas Liat系统是一种耗时15分钟的诊断检查,用于检测咽喉培养物中的甲型链球菌(Strep A),此检查在一种已获得美国食品和药品管理局临床检验改进修正计划(CLIA)豁免的用户友好自动PCR平台上运行。
CLIA豁免允许在非传统实验室地点进行Roche(Basel,Switzerland)cobas Liat系统Strep A检验,包括医师办公室、急诊室、保健诊所、药学临床和其他医疗机构。
Cobs Liat系统是一种快速、易用、紧凑的PCR平台,设计用于床旁按需检查,如医师办公室、药房、以及医院和卫星实验室。此系统配备全自动触摸屏导引操作,操作者需要接受的培训量最少,随时可以使用。该系统包括cobas Liat分析仪——一种小巧的台式分析仪,由一组广泛的仪器保护,并组合了越来越多的检测方法,包括cobas甲型/乙型流感、cobas甲型/乙型流感和RSV,以及Cobas Strep A。
“今天的决定允许在此前依赖快速抗原技术的临床环境中使用cobas Strep A检验,原本使用的技术灵敏度较低,常需要进行确证检验,”Roche Diagnostics的首席运营官,Roland Diggelmann说明。“Cobas Strep A检查大约需要15分钟的时间出具报告,相对于需要使用培养物进行检查要经过数天才能得出结果的情况而言,新的方法改善了患者和专业医疗人员的临床经验。”

Related Links:
Roche 

New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Glucose Tolerance Test
NERL Trutol
New
PBC Assay
Primary Biliary Cholangitis Assays
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Ear wax could be a possible screening medium for Parkinson’s disease (Photo courtesy of 123RF)

Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules

Current tests for Parkinson’s disease (PD) rely heavily on clinical scales and neuroimaging, which are often subjective, expensive, and ill-suited for routine screening. Since most treatments only slow... Read more

Molecular Diagnostics

view channel
Image: A family of molecules could help diagnose and treat breast cancer (Photo courtesy of Shutterstock)

Molecular Biomarkers Pave Way for New Tests to Diagnose and Predict Breast Cancer

Despite playing essential roles in tissue development and immune protection, the contribution of proteoglycans in cancer remains poorly understood. Some proteoglycans appear to shield the body from cancer,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: T cell immunity could be a marker for early Parkinson’s treatment (Photo courtesy of Shutterstock)

T Cells in Blood Can Detect Parkinson's Years Before Diagnosis

Diagnosing Parkinson’s disease before the appearance of motor symptoms remains one of neurology’s most significant challenges. Patients can go years—even decades—without a diagnosis, as subtle early indicators... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.